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Purpose: To determine the rate of cerebrospinal ﬂuid (CSF) pleocytosis among children presenting with
status epilepticus (SE) without proven central nervous system infection.
Method: We performed a retrospective cross-sectional study of all patients aged one month to 21 years
of age who were evaluated in a single pediatric emergency department (ED) for SE between 1995 and
2012. We limited our study to those children who had a CSF culture obtained and excluded those
children with proven viral or bacterial infection. We deﬁned SE in a patient who had a single seizure or a
cluster of seizures without regaining consciousness which lasted 30 min or longer. We deﬁned CSF
pleocytosis as a CSF white blood cells (WBC) > 10 cells/mm3 and a peripheral leukocytosis as
WBC  15,000 cells/mm3. We compared the rate of CSF pleocytosis between children with and without
peripheral leukocytosis using the Fisher’s exact test.
Results: We identiﬁed 289 ED visits for SE, of which 178 (62%) met study inclusion criteria. Seven
children (4%, 95% conﬁdence interval 1.7–8.2%) had CSF pleocytosis. More children with peripheral
leukocytosis had CSF pleocytosis: (8.6% with peripheral leukocytosis vs. 0.9% without leukocytosis,
p = 0.01).
Conclusion: CSF pleocytosis is relatively uncommon among children with prolonged seizures, even in the
presence of peripheral leukocytosis. Therefore, all children with CSF pleocytosis after status epilepticus
need comprehensive evaluation for central nervous system infection.
 2014 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.
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Children presenting to the emergency department (ED)
with status epilepticus (SE) pose a clinical challenge: some are
intubated, others are postictal or heavily sedated from the use of
anti-epileptic medication. Laboratory evaluation of these
children may be equally challenging given the presence of seizure
mediated leukocytosis and possibly cerebrospinal ﬂuid (CSF)
pleocytosis. Seizure mediated CSF pleocytosis, a phenomenon
referred to as ictal pleocytosis1,2 is the result of a transient
disruption to the brain barrier and possibly due to the induced
peripheral leukocytosis. The rate and clinical importance of
ictal pleocytosis is unknown, since it is indistinguishable from
other cases of culture-negative CSF pleocytosis. Yet, some
inferences are made attributing mild CSF pleocytosis to ictal* Corresponding author. Tel.: +1 617 355 6624.
E-mail address: amir.kimia@childrens.harvard.edu (A.A. Kimia).
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1059-1311/ 2014 British Epilepsy Association. Published by Elsevier Ltd. All rights repleocytosis3 offering ‘corrections’ to CSF pleocytosis cut-off
values among these patients.
Clinicians therefore use the overall rate of pleocytosis reported
in patients evaluated for seizures as a surrogate for the upper
range of potential ictal pleocytosis rates. Existing data on SE related
CSF pleocytosis is limited to subgroups of SE, such as children with
febrile seizures SE (showing rates of 1%),4 or patients with different
deﬁnitions of SE and CSF pleocytosis (describing rates of 18%),3 but
these results cannot be easily generalized.
We sought to determine the rate of CSF pleocytosis among
all children presenting with SE (without central nervous




We performed a cross-sectional study of all children aged
one month to 21 years of age who were evaluated for SE in aserved.
K.B. Johnson et al. / Seizure 23 (2014) 573–575574single urban, tertiary care pediatric ED between 1995 and 2012.
The ED serves approximately 55,000 patients per year. The study
protocol was approved by the institutional review board.
2.2. Patient identiﬁcation
Case identiﬁcation was conducted in two phases. First, for
the initial screening, we created a computer-assisted key word
screening tool called regular-expression matching.5,6
This technique provides a more comprehensive and inclusive
search than keyword searching by including misspelled and
mistyped variations. The output of the search tool was further
reﬁned by manual medical chart review.
2.3. Patient population
We included children with SE, deﬁned as a single seizure or a
cluster of seizures without return to consciousness lasting 30 min
or longer.7–9We limited this investigation to children who also had
a CSF culture obtained. We excluded children with a proven central
nervous system infection leading to CSF pleocytosis deﬁned by a
positive CSF bacterial cultures, CSF pleocytosis with a positive
blood culture, positive enterovirus CSF polymerase chain reaction
(PCR) test or herpes simplex virus PCR. We also excluded children
with signiﬁcant head trauma or neurosurgical intervention within
seven days before ED presentation, known malignancy, known
ingestion, ventricular shunt, immunocompromised state, non-
convulsive status epilepticus, or a traumatic lumbar puncture
(deﬁned as CSF red blood cells 10,000 cells/mm3).4
2.4. Data collection
The complete hospital medical records from the index visit
and the following week of all study patients were reviewed
by one of three study investigators (KJ, KM and TL). The
following factors were abstracted: patient demographics, clinical
features, laboratory and microbiology results and clinical
outcome. We deﬁned fever as temperature greater than 38 8C
measured at home or in the ED. We deﬁned antibiotics
pretreatment if any antibiotics were given within the 48 h
preceding the performance of the LP. When attending and trainee
medical records differed, study data was abstracted from the
attending documentation. Findings were considered present ifTable 1
Patient characteristics.
Characteristic With CSF pleocytosis (n = 7) 
Demographics
Median age (years) (IQR) 4.2 (3.1–9.1) 
Female gender 4 (57%) 
History
No prior seizures 4 (57%) 
On AED at home 2 (29%) 
History of fever 5 (71%) 
Localization 6 (86%) 
Physical examination
Ongoing seizure activity in ED 7 (100%) 
Management
Antibiotics prior to LP 3 (43%) 
Intubated in the ED 4 (57%) 
Died (n) 0 
Laboratory studies
Peripheral WBC > 15,000 cell/mm3 6 (86%) 
Enteroviral PCR obtained (n) 3 
HSV PCR obtained (n) 6 
*** stand for non-applicable.they were documented either by the resident or attending
physician and missing if not documented by any treating
clinician. Data elements missing from ED documentation were
abstracted from Neurology consult and discharge summary
notes in that order.
2.5. Outcome measure
Our primary outcome was rate of CSF pleocytosis deﬁned as a
CSF WBC  10 cells/mm3.10
For cases in which red blood cells ‘contaminated’ the sample we
used a corrected CSF WBC count deﬁned as a WBC[correc-
ted] = WBC[observed]  RBC[observed]/500.
2.6. Statistical analysis
We limited our primary analysis to those children who had
both CSF cell count and cultures sent (in order to reliably exclude
patients with acute bacterial meningitis). We performed
univariate analysis using Fishers exact test for categorical data
and Mann–Whitney U test for continuous data. Descriptive
statistics were used to describe rates.
Our secondary analysis involved only the subgroup of patients
who had peripheral leukocytosis – deﬁned as peripheral WBC
count >15,000/mm3. We used the Statistical Program for the Social
Sciences (IBM SPSS Statistic Version 21, IBM Inc., Chicago, IL).
3. Results
During the 17-year study period, there were 937,566 ED visits
for patients younger than 21 years of age (eFig. 1). We identiﬁed a
cohort of 594 visits for SE, of which 220 (37%) were acute
symptomatic or had fever and 178 met our inclusion criteria. The
median patient age was 2.7 years [interquartile range (IQR) 1.3–
5.5 years] and 46% were female. All 178 children were admitted
to the hospital from the ED. Seven patients (3.9%) had CSF
pleocytosis [95% CI 1.7–8.2%]. We compared the clinical and
laboratory characteristics of the 171 patients without CSF
pleocytosis to the seven with CSF pleocytosis. (Table 1) We also
examined the peripheral WBC count in children with and
without CSF pleocytosis (Fig. 1). More children with peripheral
leukocytosis had CSF pleocytosis: (8.6% with peripheral leuko-














Fig. 1. Distribution of CSF WBC counts for patients with and without peripheral
leukocytosis.
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online version, at http://dx.doi.org/10.1016/j.seizure.2014.03.015.
Since viral studies become available during later years of our
study, only 6 children with CSF pleocytosis (85.7%) and 46 children
without CSF pleocytosis (26.9%) had Herpes simplex virus
polymerase chain reaction studies (HSV PCR) sent. Fewer children
had enterovirus polymerase chain reaction studies (EV PCR) sent [3
children with CSF pleocytosis (42.9%) and 9 children (5.2%) without
CSF pleocytosis].
4. Discussion
We assembled a large retrospective cohort of children who had
an LP done for the evaluation for SE. Among these children, CSF
pleocytosis rate in the absence of proven infection was very low,
with a slightly higher rate among children with peripheral
leukocytosis. We therefore conclude that in assessment of CSF
WBC obtained from a child with SE, an infection should be
considered, as seizure driven pleocytosis is relatively uncommon.
Ictal pleocytosis, ﬁrst described in the 1920s1 involves a
transient disruption the blood brain barrier2 and induction of
peripheral leukocytosis. The average number of CSF WBCs
resulting from ictal pleocytosis is not well described, but some
authors will describe pleocytosis as CSF WBC count >12 cells/mm3
after ‘adjusting’ for ictal pleocytosis.3 Rates of overall CSF
pleocytosis were described in selected subcategories of SE. As
part of the FEBSTAT study Frank et al.4 reported a rate of 1% (1/136)
among children who had non-traumatic LPs done for evaluation of
prolonged febrile seizures. A rate corresponding with reported rate
among non-SE febrile seizure cases.11–13 Singh et al. reported a rate
of 18% (16/89) in a prospective of children with SE, mirroring the
patient population to our cohort. However, the results are hard to
compare due to different criteria used for deﬁning SE (seizure
lasting more than 20 min) and CSF pleocytosis (CSF WBC count
>5 cells/mm3).
Our study ﬁndings need to be interpreted in the setting of data
acquisition. Ictal pleocytosis is a transient phenomenon, yet our
ability to analyze the temporal association between seizure
activity and CSF pleocytosis was limited by the retrospective
design of our study. Not all children with SE had LP done,
introducing a selection bias into our ﬁndings, choosing the sicker
patients. This bias, however, suggests that the true rate of ictal
pleocytosis could be even lower than our reported rate. The latter is
true for our limited viral testing, which leads to underestimation of
viral meningitis cases, accounting for some of the pleocytosis cases
and is particularly true for encephalopathic patients in whom
infectious and immune-mediated cases are likely to account for upto 80% of the cases.14 Although all children in this study had a CSF
culture obtained, some children were pretreated with antibiotics
prior to diagnostic lumbar puncture that may have rendered
cultures falsely negative.15 Finally, the low incidence of CSF
pleocytosis prevented a detailed analysis of patient characteristics
associated with this phenomenon.
Future directions could include better characterizing the
relationship between peripheral leukocytosis and CSF pleocytosis.
This would require larger numbers of patients who had CSF
pleocytosis, but could result in clinically useful prediction models
to guide the workup of pediatric patients with CSF pleocytosis.
We conclude that children with CSF pleocytosis after SE need
comprehensive evaluation for central nervous system infections,
echoing recommendations for the interpretation of CSF results in
children after a seizure.11,16 Maintaining clinical suspicion for CNS
infection in children with CSF pleocytosis will increase the
likelihood that these acutely ill children receive appropriate care.
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